USD 23.71
(-2.39%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 365.22 Million USD | 3.44% |
2022 | 341.06 Million USD | 7.34% |
2021 | 317.74 Million USD | 37.0% |
2020 | 231.93 Million USD | 3.96% |
2019 | 223.1 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 101.63 Million USD | -7.59% |
2024 Q1 | 109.97 Million USD | 26.31% |
2023 Q4 | 87.06 Million USD | -6.11% |
2023 Q3 | 92.73 Million USD | 2.31% |
2023 Q2 | 90.63 Million USD | -4.38% |
2023 Q1 | 94.79 Million USD | 17.53% |
2023 FY | 352.8 Million USD | 3.44% |
2022 Q3 | 84.41 Million USD | -2.23% |
2022 Q2 | 86.34 Million USD | -3.68% |
2022 Q1 | 89.64 Million USD | 17.57% |
2022 FY | 341.06 Million USD | 7.34% |
2022 Q4 | 80.65 Million USD | -4.46% |
2021 Q4 | 76.25 Million USD | -4.28% |
2021 FY | 317.74 Million USD | 37.0% |
2021 Q3 | 79.66 Million USD | 2.06% |
2021 Q2 | 78.05 Million USD | -6.84% |
2021 Q1 | 83.78 Million USD | 28.54% |
2020 Q4 | 65.17 Million USD | 1.87% |
2020 Q3 | 63.98 Million USD | 24.5% |
2020 Q1 | 51.38 Million USD | 0.0% |
2020 Q2 | 51.38 Million USD | 0.0% |
2020 FY | 231.93 Million USD | 3.96% |
2019 FY | 223.1 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alcon Inc. | 5.6 Billion USD | 93.487% |
AptarGroup, Inc. | 1.26 Billion USD | 71.092% |
Baxter International Inc. | 4.97 Billion USD | 92.659% |
Becton, Dickinson and Company | 9.15 Billion USD | 96.01% |
Bausch + Lomb Corporation | 2.5 Billion USD | 85.414% |
Haemonetics Corporation | 676.53 Million USD | 46.016% |
Envista Holdings Corp | 1.45 Billion USD | 74.821% |
ResMed Inc. | 2.6 Billion USD | 86.0% |
Teleflex Incorporated | 1.64 Billion USD | 77.824% |
West Pharmaceutical Services, Inc. | 1.12 Billion USD | 67.656% |